Cite
HARVARD Citation
Yamanaka, H. et al. (n.d.). THU0092 The advantage of early intervention by tocilizumab for rheumatoid arthritis - full analysis of all-case postmarketing surveillance in 7, 901 patients in japan. Annals of the rheumatic diseases. pp. 184-185. [Online].